Schedule of outcome measurements
| Baseline | Primary registration | Secondary registration | 1st outpatient visit after GA | 3 months | 6 months | 12 months | |
| GA | ◯ | · | |||||
| Patient characteristics* | ◯ | ||||||
| Oncologist characteristics† | △ | ||||||
| Number of ageing-related conversations | Ⓞ | ||||||
| Quality of ageing-related conversations | Ⓞ | ||||||
| RIAS37 and SHARE36 | Ⓞ | ||||||
| CARE-1038 39 | Ⓞ | Ⓞ | Ⓞ | ||||
| TiOS40 41 | Ⓞ | ||||||
| CTCAE | Ⓞ | ||||||
| Prevalence of dose modifications | Ⓞ | ||||||
| Implementation of GA-guided management | Ⓞ | Ⓞ | |||||
| GA evaluation | ◯ | ||||||
| QPL evaluation | · | ||||||
| GA+QPL evaluation | △ | △ | |||||
| PRO-CTCAE33–35 | Ⓞ | Ⓞ | Ⓞ | ||||
| IADL30 | Ⓞ | Ⓞ | Ⓞ | ||||
| QOL31 32 | Ⓞ | Ⓞ | Ⓞ | ||||
| Overall survival rate | Ⓞ | Ⓞ |
◯ will be evaluated among all participants at the primary registration. Ⓞ will be evaluated among all participants after the secondary registration. · will be evaluated among participants in the intervention arm. △ will be evaluated among attending oncologists in the intervention arm.
*Patient characteristics include age, gender, highest level of education, employment status, marital status, financial concerns and self-rated health.
†Oncologist characteristics include age, gender, years in practice and years in oncology practice.
CARE-10, Consultation and Relational Empathy measure-10; CTCAE, Common Terminology Criteria for Adverse Events; GA,geriatric assessment; IADL, Instrumental Activities of Daily Living; PRO-CTCAE, Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events; QOL, quality of life; QPL, question prompt list; RIAS, Roter interaction analysis system; SHARE, setting, how to deliver bad news, additional information, reassurance and emotional support; TiOS, Trust in Oncologists Scale.